Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study

Teriparatide (recombinant 1–34 N-terminal sequence of human parathyroid hormone) for the treatment of osteoporosis should be prescribed with caution in patients with severe stages of chronic kidney disease (CKD). However, in clinical settings, physicians and surgeons who treat such patients have few...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Atsushi, Yoshiki, Fumito, Taketsuna, Masanori, Kajimoto, Kenta, Enomoto, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117886/
https://www.ncbi.nlm.nih.gov/pubmed/27895472
http://dx.doi.org/10.2147/CIA.S120175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117886/
https://www.ncbi.nlm.nih.gov/pubmed/27895472
http://dx.doi.org/10.2147/CIA.S120175

Ejemplares similares